ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|20|2272-2281

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.20, 2009-07, pp. : 2272-2281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SHIP2: An Emerging Target for the Treatment of Type 2 Diabetes Mellitus

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 291-298

Bentham Science Publishers

Access to resources Recommend Favorite

Cot/Tpl-2 Protein Kinase as a Target for the Treatment of Inflammatory Disease

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 611-622

Bentham Science Publishers

Access to resources Recommend Favorite

A review of the emerging profile of the anti-inflammatory drug oxaprozin

By Dallegri Franco   Bertolotto Maria   Ottonello Luciano  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 777-785

Informa Healthcare

Access to resources Recommend Favorite

Blood coagulation factor Xa as an emerging drug target

By Borensztajn Keren   Spek C Arnold  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 341-349

Informa Healthcare

Access to resources Recommend Favorite

The Cholinergic System: An Emerging Drug Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2124-2133

Bentham Science Publishers

Access to resources Recommend Favorite